Analysis of publicly available breast-cancer datasets revealed that SPHK1 expression is markedly elevated in TNBC patient samples and that high SPHK1 levels are significantly associated with poor prognosis (Figure S1A–C). This evidence concerns the gene SPHK1 and breast carcinoma.